Clinical trial · Interventional
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
Development and Evaluation of Comprehensive Care Program for Their Return to Normal Life and Community Among Lung Cancer Survivors
NCT05078918CI-TRIAL-00062279unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to develop a comprehensive care program for their return to normal life and community among lung cancer survivors and evaluate the effectiveness of the program.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Lung Neoplasm | Lung Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Comprehensive care program | Other | — | UNRESOLVED |
| Usual care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Comprehensive care program
- description
- Intervention group receiving newly developed comprehensive care program pre- and post-operatively.
- interventionNames
- Other: Comprehensive care program
- type
- ACTIVE_COMPARATOR
- label
- Usual care
- description
- Control group receiving usual care
- interventionNames
- Other: Usual care
Primary outcomes (1)
- measure
- Mental adjustment to cancer at 6 months after surgery
- timeFrame
- 6 months after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with non-small cell lung cancer(NSCLC) and scheduled for curative resection. * NSCLC with clinical stage Ⅰ-Ⅲ * Patients who understood the study and gave written informed consent. Exclusion Criteria: * Recurred lung cancer * Patients with extra-pulmonary synchronous double primary cancer. * Patients with history of other cancer diagnosis or treatment in the last 3 years. Drop Criteria: * When surgery was canceled or pathologic stage IV was confirmed after surgery. * When the tumor was not found to be non-small cell lung cancer, including benign tumor, after surgery * Withdrawal informed consent.
References
Publications (1)
- DERIVEDJung W, Ahn A, Lee G, Kong S, Kang D, Lee D, Kim TE, Shim YM, Kim HK, Cho J, Cho J, Shin DW. Supporting Life Adjustment in Patients With Lung Cancer Through a Comprehensive Care Program: Protocol for a Controlled Before-and-After Trial. JMIR Res Protoc. 2024 Feb 13;13:e54707. doi: 10.2196/54707. PMID 38349712